Adiposopathy: Sick Fat Causes High Blood Sugar, High Blood Pressure and Dyslipidemia
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Adiposopathy is defined as pathological adipose tissue function that may be promoted and exacerbated by fat accumulation (adiposity) and sedentary lifestyle in genetically susceptible patients. Adiposopathy is a root cause of some of the most common metabolic diseases observed in clinical practice, including Type 2 diabetes mellitus, hypertension and dyslipidemia. The most common term for the metabolic consequences of adiposopathy is currently 'the metabolic syndrome'. Drug usage to treat the metabolic syndrome has focused on the safety and efficacy of treatments directed towards individual components of the metabolic syndrome, and not so much upon adiposopathy itself. However, enough is known about the pathophysiology of adiposopathy to propose diagnostic criteria. Regulatory issues are important obstacles to the research and development of new drug treatments for the metabolic syndrome. It is hoped that these obstacles can, to some extent, be addressed and overcome by clearly defining and increasing our understanding of adiposopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“Clinicians also have the intuitive sense that a long-term commitment towards treating these multiple metabolic risk factors improves the health of their patients, which is again supported by the medical literature [13].”
BackgroundGoodpaster, B. H., Leland Thaete, F., Simoneau, J.-A., & Kelley, D. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1579 · Cited by 1,012
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Relationships of generalized and regional adiposity to insulin sensitivity in men.
Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., & Grundy, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118083 · Cited by 759
Self-citationStern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735 · cited 1×
“In fact, even in patients without diabetes mellitus, diagnosis of the metabolic syndrome appears to be inferior to established prediction models for either Type 2 diabetes or CHD, such as the Diabetes Predicting Model and Framingham Risk Score [11].”
MethodBays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664
Self-citationThe expression of adipogenic genes is decreased in obesity and diabetes mellitus
Nadler, S. T., Stoehr, J. P., Schueler, K. L., Tanimoto, G., Yandell, B. S., & Attie, A. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11371 · Cited by 386 · cited 1×
“Specifically, the expression of many genes normally associated with adipocyte differentiation appeared to be downregulated with obesity [41].”
BackgroundCurrent and investigational antiobesity agents and obesity therapeutic treatment targets
Bays, H. E. (2004) · Obesity Research · doi:10.1038/oby.2004.151 · Cited by 228 · cited 10×
“§§§§The relationship of elevated leptin levels and obesity are well-established [1].”
BackgroundInfluentialSelf-citationAdipose Tissue Metabolites and Insulin Resistance in Nondiabetic Asian Indian Men
Abate, N., Chandalia, M., Snell, P. G., & Grundy, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031843 · Cited by 201 · cited 4×
“Many persons originating from the Indian subcontinent manifest insulin resistance, even in the absence of obesity [27–29].”
BackgroundResultInfluentialSelf-citation
Cited by
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530
Self-citationBays, H. E., Chapman, R. H., Grandy, S., & the SHIELD Investigators’ Group (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01336.x · Cited by 510
Self-citationBays, H. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.038 · Cited by 431
“, Asians) (3); 3) and the diagnosis of the metabolic syndrome did not appear to be a better predictor of future metabolic disease than the assessment of its individual components (17).”
BackgroundInfluentialSelf-citationNew obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Bays, H. E., Tighe, A. P., Sadovsky, R., & Davidson, M. H. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 265
Self-citation
Metadata
- Authors
- Bays, H., Abate, N., & Chandalia, M.
- Venue
- Future Cardiology
- Publisher
- Informa UK Limited
- Published
- 2005-01
- Volume
- 1
- Issue
- 1
- Pages
- 39-59
- ISSN
- 1479-6678 (ISSN-L)
- 1744-8298
- OpenAlex
- W2041794190
- Cited by
- 105
- References
- 11
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adiposopathy: Sick Fat Causes High Blood Sugar, High Blood Pressure and Dyslipidemia. https://app.cochat.ai/papers/10.1517/14796678.1.1.39
- The paper
- Bays, H., Abate, N., & Chandalia, M. (2005). Adiposopathy: Sick Fat Causes High Blood Sugar, High Blood Pressure and Dyslipidemia. Future Cardiology. https://doi.org/10.1517/14796678.1.1.39
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.